Profil
Julie Maltzman is currently Chief Medical Officer at Adicet Bio, Inc. since 2025.
Formerly, Dr. Maltzman was Chief Medical Officer at IconOVir Bio, Inc. and VP, Global Head-GI Cancers & Cancer Immunotherapy at Genentech, Inc. Dr. Maltzman earned a doctorate from The University of Colorado.
Postes actifs de Julie Maltzman
| Sociétés | Poste | Début |
|---|---|---|
| ADICET BIO, INC. | Directeur Technique/Scientifique/R&D | 13/01/2025 |
Anciens postes connus de Julie Maltzman
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Directeur Technique/Scientifique/R&D | - |
Formation de Julie Maltzman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adicet Bio, Inc.
Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
















